BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28369405)

  • 1. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.
    Campos NG; Tsu V; Jeronimo J; Njama-Meya D; Mvundura M; Kim JJ
    Health Policy Plan; 2017 Sep; 32(7):956-968. PubMed ID: 28369405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
    Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
    BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.
    Campos NG; Tsu V; Jeronimo J; Mvundura M; Lee K; Kim JJ
    Int J Cancer; 2017 Mar; 140(6):1293-1305. PubMed ID: 27925175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.
    Campos NG; Alfaro K; Maza M; Sy S; Melendez M; Masch R; Soler M; Conzuelo-Rodriguez G; Gage JC; Alonzo TA; Castle PE; Felix JC; Cremer M; Kim JJ
    Prev Med; 2020 Feb; 131():105931. PubMed ID: 31765712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
    Campos NG; Mvundura M; Jeronimo J; Holme F; Vodicka E; Kim JJ
    BMJ Open; 2017 Jun; 7(6):e015048. PubMed ID: 28619772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
    Campos NG; Castle PE; Wright TC; Kim JJ
    Int J Cancer; 2015 Nov; 137(9):2208-19. PubMed ID: 25943074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.
    Campos NG; Tsu V; Jeronimo J; Mvundura M; Kim JJ
    BMC Cancer; 2017 Nov; 17(1):791. PubMed ID: 29178896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in Peru.
    Goldie SJ; Levin C; Mosqueira-Lovón NR; Ortendahl J; Kim J; O'Shea M; Diaz Sanchez M; Mendoza Araujo MA
    Rev Panam Salud Publica; 2012 Dec; 32(6):426-34. PubMed ID: 23370186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country.
    Vanni T; Luz PM; Grinsztejn B; Veloso VG; Foss A; Mesa-Frias M; Legood R
    Int J Cancer; 2012 Jul; 131(2):E96-104. PubMed ID: 21964797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand.
    Sharma M; Ortendahl J; van der Ham E; Sy S; Kim JJ
    BJOG; 2012 Jan; 119(2):166-76. PubMed ID: 21481160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Offering Cervical Cancer Screening with HPV Self-Sampling among African-American Women in the Mississippi Delta.
    Campos NG; Scarinci IC; Tucker L; Peral S; Li Y; Regan MC; Sy S; Castle PE; Kim JJ
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1114-1121. PubMed ID: 33771846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of increasing cervical cancer screening coverage in the Middle East: An example from Lebanon.
    Sharma M; Seoud M; Kim JJ
    Vaccine; 2017 Jan; 35(4):564-569. PubMed ID: 28017434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness.
    Goldie SJ; Kuhn L; Denny L; Pollack A; Wright TC
    JAMA; 2001 Jun; 285(24):3107-15. PubMed ID: 11427139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries.
    Campos NG; Jeronimo J; Tsu V; Castle PE; Mvundura M; Kim JJ
    Cancer Epidemiol Biomarkers Prev; 2017 Oct; 26(10):1500-1510. PubMed ID: 28710075
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns.
    Portnoy A; Campos NG; Sy S; Burger EA; Cohen J; Regan C; Kim JJ
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):22-30. PubMed ID: 31666282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer prevention in Morocco: a model-based cost-effectiveness analysis.
    Messoudi W; Elmahi T; Nejjari C; Tachfouti N; Zidouh A; Saadani G; Moriña D; Diaz M
    J Med Econ; 2019 Nov; 22(11):1153-1159. PubMed ID: 31135231
    [No Abstract]   [Full Text] [Related]  

  • 17. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
    Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
    Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
    Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Masch R; Cremer M; Kim JJ
    Int J Gynaecol Obstet; 2019 Apr; 145(1):40-46. PubMed ID: 30702142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
    Nguyen DTN; Simms KT; Keane A; Mola G; Bolnga JW; Kuk J; Toliman PJ; Badman SG; Saville M; Kaldor J; Vallely A; Canfell K
    BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35241461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
    Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
    BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.